Professional
Added to YB: 2024-06-11
Pitch date: 2024-06-04
CBUS [bearish]
Cibus, Inc.
+84.81%
current return
Author Info
Bonitas Research is an activist short seller sharing their research. Sign up for the newsletter.
Company Info
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits.
Market Cap
$145.0M
Pitch Price
$11.26
Price Target
N/A
Dividend
N/A
EV/EBITDA
-10.75
P/E
-1.20
EV/Sales
94.52
Sector
Biotechnology
Category
N/A
SHORT CIBUS (CBUS)
CBUS: Short as gene-editing tech fails to bring new crops to market despite 20+ years of trying. Partnerships ended, $250M write-down on $750M of intangibles. Chair accused of misleading investors, pledging shares & selling 300K by July. Burning $5M/month with little revenue, needs capital by Sept.
Read full article (3 min)